Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Nat Commun. 2012;3:1282. doi: 10.1038/ncomms2282.
Cellular microparticles are vesicular plasma membrane fragments with a diameter of 100-1,000 nanometres that are shed by cells in response to various physiological and artificial stimuli. Here we demonstrate that tumour cell-derived microparticles can be used as vectors to deliver chemotherapeutic drugs. We show that tumour cells incubated with chemotherapeutic drugs package these drugs into microparticles, which can be collected and used to effectively kill tumour cells in murine tumour models without typical side effects. We describe several mechanisms involved in this process, including uptake of drug-containing microparticles by tumour cells, synthesis of additional drug-packaging microparticles by these cells that contribute to the cytotoxic effect and the inhibition of drug efflux from tumour cells. This study highlights a novel drug delivery strategy with potential clinical application.
细胞微粒是直径为 100-1000 纳米的带有囊泡的细胞膜碎片,在受到各种生理和人为刺激时由细胞释放。在这里,我们证明肿瘤细胞来源的微粒可用作载体来传递化疗药物。我们发现,与化疗药物孵育的肿瘤细胞将这些药物包装到微粒中,这些微粒可以被收集并用于有效杀死小鼠肿瘤模型中的肿瘤细胞,而没有典型的副作用。我们描述了这个过程中涉及的几种机制,包括肿瘤细胞摄取含药微粒、这些细胞合成有助于细胞毒性作用的额外的药物包装微粒以及抑制肿瘤细胞内药物外排。这项研究强调了一种具有潜在临床应用的新的药物传递策略。